According to the Zhitong Finance App, Changfeng Pharmaceutical (02652) issued an announcement to allocate and issue 21.7477 million new H shares under general authorization on August 6, 2026.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.